[e-drug] Summary of MSF's participation & events @ International AIDS Conference 2010

E-DRUG: Summary of MSF's participation & events @ International AIDS Conference 2010
--------------------------------------------------------------------

Please find in text a summary of MSF's presence at this year's
International AIDS Conference in Vienna.
For full details of MSF @ IAC, visit http://aids2010.msf.org

MSF @ the XVIII International AIDS Conference 2010

MSF Pre Conference Satellite
16.07. 09:30 - 11:00
Interactions between HIV, other priority health conditions and health
systems strengthening
Location: TBA

Satellite
22.07. 18:30 - 20:30
Close the Gaps: How to counter the retreat from HIV treatment scale up
Satellite Session
Location: Conference Area, Session Room 7

Bridging Sessions
23.07. 11:00 - 12:30
No Resources, No Results
Bridging Session
Location: Conference Area, Session Room 9

Follow MSF’s Oral Abstract Presentations

19.07. 14:30 - 14:45
High loss-to-follow up rate among individuals in urgent need of
antiretroviral treatment in Malawi and Kenya: Cohort reporting that does
not include this group is biased and misleading
Location: Session Room 9

19.07. 14:30 - 14:45
TB/HIV integration: Lessons learned from implementation of a TB/HIV
“one-stop shop” at primary health care clinics in rural Lesotho
Location: Session Room 8

21.07. 14:30 - 14:45
Comparison of integrated and vertical antiretroviral treatment programme
outcomes in nine countries in sub-Saharan Africa
Location: Session Room 2

21.07. 14:45 - 15:00
Provision of antiretroviral treatment in conflict settings: The experience
of MSF
Location: Session Room 2

21.07. 16:45 – 17:00
Safety of efavirenz in first-trimester of pregnancy: a systematic review
and meta-analysis of outcomes from observational cohorts
Location: Session Room 9

22.07. 13:00 – 14:30
LATE BREAKER SESSION
Early initiation of antiretroviral therapy and associated reduction in
mortality, loss to follow up and hospitalisation in a routine programme in
Lesotho
Location: Session Room 1

22.07. 14:30 - 14:45
A decentralised, patient-centred model of care for drug-resistant
tuberculosis in a high HIV prevalence setting
Location: Session Room 5

22.07. 17:00 - 17:15
Distribution of antiretroviral therapy through self-forming groups of
people living with HIV in Tete Province, Mozambique
Location: Session Room 2

22.07. 17:30 - 17:45
LATE BREAKER!
“TB is a disease that is flying to the air”: traditional concepts and
perceptions of tuberculosis and drug-resistant tuberculosis and the
potential for home-based care
Location: Session Room 5

23.07. 11:30 - 11:45
LATE BREAKER!
Cost and cost-effectiveness of switching to a TDF-based first-line regimen
in rural Lesotho
Location: Session Room 4

MSF in the field
All presentations take place in the Global Village (Hall A, booth 821)
19.07. 15:00
Living with TB in Kyrgyzstan prisons – a grim reality
20.07. 10:00
MSF in Swaziland
22.07. 10:00
Support for HIV-positive children

Workshops

19.07. 14:30 - 18:00
Improving access to ARVs through compulsory licensing: A how-to course
Location: Conference Area, Mini Room 6

20.07. 11:00 - 12:30
How to Manage Suspicions on Second-line ART Failures in Developing
Countries
Location: Conference Area, Mini Room 3

20.07. 11:00 - 12:30
Human Resources: the Ultimate Bottleneck
Location: Conference Area, Session Room 6

20.07. 13:00 - 14:00
Bridging the Divide: Inter-Disciplinary Partnerships for HIV and Health
Systems
Location: Conference Area, Session Room 4

20.07. 14:30 - 16:00
Sustaining Access to Effective Antiretroviral Therapy: Past Lessons, Future
Challenges
Symposium
Location: Global Village, Session Room 1

Watch with MSF
22.07. 10:30
The Positive Ladies Soccer Club
A film by Joanna Stavropoulou for Médecins Sans Frontières
Global Village, Hall A
MSF’s posters exhibited in the poster section of Hall B

19.07. 12:30 - 14:30 MOPE1048
HIV treatment in DR Congo: backtracking on international funding
commitments compounds scale-up implementation difficulties

19.07. 12:30 - 14:30 TBA
Weight loss after the first year of stavudine-containing antiretroviral
therapy and its key determinants at primary health care level in Kigali,
Rwanda

19.07. 12:30 - 14:30 MOPE022
Reasons why women default from a prevention of mother-to-child transmission
(PMTCT) programme in the informal settlement of Kibera, Nairobi, Kenya:
Results from a qualitative study

19.07. 12:30 - 14:30 MOPE0216
Effectiveness of a PMTCT programme in rural western Kenya: The experience
of Médecins Sans Frontières

19.07. 12:30 - 14:30 MOPE0216
Consequences of backtracking on international funding commitments for
HIV/AIDS treatment in several African countries

19.07. 12:30 - 14:30 MOPE0885
STAR awards – the effect of a non-monetary team based incentive system on
staff performance in a high-prevalence setting, Malawi

19.07. 14:30 - 16:00 MOPE0856
Outcomes of tuberculosis in HIV-infected children treated in integrated
outpatient clinics in Yangon, Myanmar

19.07. 14:30 – 16:00 MOPE0891
Closing the gap: Decentralised, patient-centred and integrated TB/HIV care
in a rural region in Swaziland

20.07. 12:30 - 14:30 TU15119
Poor outcome of single-agent chemotherapy with vincristine in combination
with ART for AIDS-related Kaposi’s sarcoma (AKS) in central Malawi

21.07. 12:30 - 14:30 WEPE0833
Reduction in population mortality associated with scaling-up HIV/AIDS care
and antiretroviral treatment in rural Malawi: Evidence from death
registers, coffin sales and church funerals

21.07. 12:30 - 14:30 WEPE0843
Systematic review of task shifting for HIV/AIDS treatment in sub-Saharan
Africa

22.07. 12:30 - 14:30 THPE0791
Antiretroviral treatment eligibility among HIV-positive individuals in WHO
clinical stage 1 and 2 at community (Health Post) level in rural Malawi:
Implications for practice

22.07. 12:30 - 14:30 THPE0170
Outcomes in children, adolescent, youth and adults on ART in Khayelitsha,
South Africa

22.07. 12:30 - 14:30 THPE0079
Duration of tenofovir-based first-line antiretroviral regimens in an
HIV/AIDS programme in rural Zambia

22.07. 14:30 - 16:00 THPE0119
Implementing a tenofovir-based first-line in a nurse-based rural district
of Lesotho is safe and feasible and increases nurse confidence in ART

22.07. 14:30 – 16:00 THPE0087
One-year immuno-virological outcomes of ART patients receiving centralised
and decentralized HIV care in Malawi

22.07. 14:30 – 16:00 THPE0126
Failure on first-line therapy and inequalities in switching to second-line
in adults treated in urban and rural ART programmes: Multicentric analysis
in 28 MSF-supported African and Asian sites

22.07. 14:30 – 16:00 THPE0405
Evaluation of Fluxo Rapido, a simplified service provision scheme for
stable patients in a decentralized HIV/AIDS care setting in Chamanculo
Health Area, Mozambique

22.07. 14:30 – 16:00 THPE0085
Women experienced a better immune recovery on HAART in Lao PDR

After hours
17.07. 19:00
MSF Beach Opening Party - Concert with DJ Trishes (FM4)
MSF Beach

18.07. 19:30
Sunny without Borders Concert with John Megill (FM4)
MSF Beach

19.07. 17:30 - 18:00
Bholoja, the pioneer of “Swazi Soul”, live in concert
Global Village

21.07. 19:30
Bholoja live in concert
MSF Beach

For full details of MSF @ IAC, visit http://aids2010.msf.org

Best,

Alexandra

Alexandra Lee
Webmaster/Online Content Editor
Medecins Sans Frontieres- Campaign for Access to Essential Medicines
+41 22 849 89 88 (Direct Line)
www.msfaccess.org
Alexandra.LEE@geneva.msf.org